Shalby Share Price

NSE
180.05
-1.73 (0.55%)
SHALBY • 13 Jun, 2025 | 03:29 PM
BUY

1Y Annualised Return

-35.22%

3Y Annualised Return

19.34%

5Y Annualised Return

21.05%

The current prices are delayed, login or Open Demat Account for live prices.

Shalby SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹54,74,358 (-15.78%)

Daily SIP of 25,000 would have become 54,74,358 in 1 year with a gain of -10,25,641 (-15.78%)

Shalby Stock Performance
Today’s Low - High
178.00
182.30
178.00
182.30
52 Week Low - High
177.45
325.00
177.45
325.00

Open

179.00

Prev. Close

181.78

Total Traded Value

1.45 Cr

View details of Market Depth
Shalby Fundamental

Market Cap (in crs)

1,944.82

Face Value

10

Turnover (in lacs)

144.64

Key Metrics
Qtr Change %
Near 52W Low of ₹177.45
-12.6
Dividend yield 1yr %
Below industry Median
0.7

Shalby Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Shalby Quarterly Revenue

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
264.89 Cr
275.63 Cr
267.54 Cr
278.89 Cr
244.23 Cr

Shalby Yearly Revenue

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
1114.55 Cr
953.18 Cr
827.44 Cr
711.37 Cr
439.96 Cr
504.22 Cr

Shalby Quarterly Net Profit/Loss

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
-12.19 Cr
-2.99 Cr
2.36 Cr
14.74 Cr
16.04 Cr

Shalby Yearly Net Profit/Loss

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
1.92 Cr
83.5 Cr
67.68 Cr
53.97 Cr
42.36 Cr
27.59 Cr
Shalby Result Highlights
  • Shalby Ltd reported a 11.3% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 19.7%.

  • Its expenses for the quarter were down by 15.4% QoQ and up 20.4% YoY.

  • The net profit decreased 636.5% QoQ and increased 15.4% YoY.

  • The earnings per share (EPS) of Shalby Ltd stood at 1.5 during Q4FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Shalby shareholding Pattern

Promoter
74.3%
Foreign Institutions
4.5%
Domestic Institutions
0.2%
Public
20.3%
Promoter
74.3%
Foreign Institutions
4.6%
Domestic Institutions
0.2%
Public
20.3%
Promoter
74.2%
Foreign Institutions
5.4%
Domestic Institutions
0.1%
Public
19.6%
Promoter
74.2%
Foreign Institutions
5.4%
Public
19.6%
Promoter
74.2%
Foreign Institutions
4.9%
Public
20.1%
Promoter
74.1%
Foreign Institutions
4.6%
Public
20.4%

Shalby Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
180.05
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
182.10
10Day EMA
184.20
12Day EMA
184.90
20Day EMA
187.20
26Day EMA
188.30
50Day EMA
192.10
100Day EMA
201.10
200Day EMA
216.80
5Day SMA
182.60
10Day SMA
182.80
20Day SMA
190.80
30Day SMA
189.50
50Day SMA
191.50
100Day SMA
199.40
150Day SMA
209.30
200Day SMA
223.70
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
42078 Rs
85148 Rs
Week Rs
100617 Rs
190813 Rs
Month Rs
93430 Rs
167320 Rs
Resistance & Support
180.12
Pivot
Resistance
First Resistance
182.24
Second Resistance
184.42
Third Resistance
186.54
Support
First Support
177.94
Second support
175.82
Third Support
173.64
Relative Strength Index
37.06
Money Flow Index
33.81
MACD
-3.40
MACD Signal
-2.38
Average True Range
5.83
Average Directional Index
14.17
Rate of Change (21)
-8.11
Rate of Change (125)
-26.35

Shalby Latest News

06 JUN 2025 | Friday

Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Credit Rating

04 JUN 2025 | Wednesday

Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

31 MAY 2025 | Saturday

Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

View More

Shalby Company background

Founded in: 2004
Managing director: Vikram Shah
Shalby Ltd was originally incorporated as a Private Limited Company with the name Shalby Hospital Private Limited on August 30, 2004. Subsequently, the Company was converted to a Public Limited Company and the name was changed to Shalby Hospital Public Limited on May 15, 2006. Further, the name of the Company was changed to Shalby Hospitals Limited on July 26, 2006 and then, again changed to Shalby Limited on February 13, 2008. Shalby Limited is an Ahmedabadheadquartered and one of the leading multispecialty chain of hospitals in India and provides highquality and economical healthcare services. The Hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations. Led by Dr. Vikram Shah, an orthopaedic surgeon, the Hospital has grown from a single hospital to a chain of multispecialty hospitals. Apart from a focus on orthopaedics, the hospitals provide advanced levels of care across various specialties such as neurology, cardiac care, critical care, oncology, and nephrology. The Hospitals, Krishna Shalby, SG Shalby, Shalby Indore and Shalby Jabalpur are accredited by the NABH. Further, Krishna Shalby and SG Shalby are also accredited by the NABL. The Hospital currently runs a panIndian chain of 11 multispecialty tertiary hospitals and 4 Single specialty Hospitals (SOCE) across 6 states with a total bed capacity of more than 2,000. Shalby has 59 outpatient clinics (OPDs) across 16 states. It also expanded global presence by opening OPDs in Kenya, Nairobi, Ethiopia, Tanzania, and Uganda in the African continent.In 2007, the Company established operations of its first multispecialty hospital, SG Shalby, at Sarkhej Gandhinagar Highway in Ahmedabad. The company commenced a new hospital Shalby Vapi at Vapi in April 2012 and thereafter it commenced a new hospital Krishna Shalby in Ahmedabad in October 2012. The company commenced a new hospital Shalby Jabalpur at Jabalpur in Madhya Pradesh in March 2015. The company commenced a new hospital Shalby Indore at Indore in August 2015. In 2016, the company executed a memorandum of understanding with ZH Private Limited to manage and operate Zynova Shalby. During the year under review, the company executed an OM agreement with Kamesh Hospital to commence operations of Shalby Mohali. In 2017, the company entered into an agreement with Bait Al Batterjee Medical Company LLC, Dubai, to provide outpatient orthopaedics and spine surgeries. The Company came up with an Initial Public Offer of 20,354,838 Equity Shares by raising capital from public aggregating to Rs 504. 8 Crores comprising a Fresh Issue of 19,354,838 Equity Shares amounting to Rs 480 Crores and an Offer for Sale of 1,000,000 Equity Shares amounting to Rs 24.8 Crore in December, 2017.With the increase in demand of digital transformation in healthcare sector, Shalby embarked its journey of digital transformation across its all hospitals from 201819. In 2020, the Company launched Video Assisted Thoracic Surgery (VATS) to reduce the incidence of surgical complications. The Liver Transplant Facility became fully operational at Shalby, Ahmedabad and Mohali.The Company incorporated a new wholly owned subsidiary Company under the name and style Mars Medical Devices Limited on April 3, 2020. The Company also incorporated whollyowned subsidiary company under the name and style Shalby Hospitals Mumbai Pvt. Ltd. on December 10, 2020. In May 2021, the Company acquired the assets of Consensus Orthopaedics, a hip and knee implant manufacturing company with its facility at El Dorado Hills, USA. The Company also commenced multispeciality rehabilitation centre at one of its Unit in 2021. The Company launched a stateoftheart Digital Spine Operation Room at SG Shalby Hospital, Ahmedabad in 2022. In September 2021, the Company launched its first Shalby Orthopedics Centre of Excellence (SOCE) in the country at Udaipur. Centralised cloud based Laboratory Information System (LIS) was launched in 2022. The Company further incorporated Shalby Advanced Technologies Inc. (SAT) in the first quarter of Fiscal 2022.In 202223, the Company launched a new product line of Uni Knee System called as Tahoe Unicompartmental Knee System or TUKS.

As of 13 Jun, 2025, SHALBY share price is ₹180.1. The stock opened at ₹179 and had closed at ₹181.8 the previous day. During today’s trading session, SHALBY share price moved between ₹178.00 and ₹182.30, with an average price for the day of ₹180.00. Over the last 52 weeks, the stock has recorded a low of ₹177.45 and a high of ₹325.00. In terms of performance, SHALBY share price has declined by 25.4% over the past six months and has declined by 35.22% over the last year.

Read More

Shalby FAQs

Shalby share price is ₹180.05 in NSE and ₹180.75 in BSE as on 13/6/2025.

Shalby share price in the past 1-year return was -35.83. The Shalby share hit a 1-year low of Rs. 177.45 and a 1-year high of Rs. 325.

The market cap of Shalby is Rs. 1944.82 Cr. as of 13/6/2025.

The PE ratios of Shalby is 23.22 as of 13/6/2025.

The PB ratios of Shalby is 1.71 as of 13/6/2025

You can easily buy Shalby shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Shalby stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -